Mol Ben W, Lai Shimona, Rahim Ayesha, Bordewijk Esmée M, Wang Rui, van Eekelen Rik, Gurrin Lyle C, Thornton Jim G, van Wely Madelon, Li Wentao
Department of Obstetrics and Gynaecology, Monash University, Clayton, Australia.
Aberdeen Centre for Women's Health Research, University of Aberdeen, Aberdeen, UK.
Res Integr Peer Rev. 2023 Jun 20;8(1):6. doi: 10.1186/s41073-023-00130-8.
To propose a checklist that can be used to assess trustworthiness of randomized controlled trials (RCTs).
A screening tool was developed using the four-stage approach proposed by Moher et al. This included defining the scope, reviewing the evidence base, suggesting a list of items from piloting, and holding a consensus meeting. The initial checklist was set-up by a core group who had been involved in the assessment of problematic RCTs for several years. We piloted this in a consensus panel of several stakeholders, including health professionals, reviewers, journal editors, policymakers, researchers, and evidence-synthesis specialists. Each member was asked to score three articles with the checklist and the results were then discussed in consensus meetings.
The Trustworthiness in RAndomised Clinical Trials (TRACT) checklist includes 19 items organised into seven domains that are applicable to every RCT: 1) Governance, 2) Author Group, 3) Plausibility of Intervention Usage, 4) Timeframe, 5) Drop-out Rates, 6) Baseline Characteristics, and 7) Outcomes. Each item can be answered as either no concerns, some concerns/no information, or major concerns. If a study is assessed and found to have a majority of items rated at a major concern level, then editors, reviewers or evidence synthesizers should consider a more thorough investigation, including assessment of original individual participant data.
The TRACT checklist is the first checklist developed specifically to detect trustworthiness issues in RCTs. It might help editors, publishers and researchers to screen for such issues in submitted or published RCTs in a transparent and replicable manner.
提出一份可用于评估随机对照试验(RCT)可信度的清单。
采用Moher等人提出的四阶段方法开发了一种筛选工具。这包括界定范围、审查证据基础、通过试点提出一系列条目以及召开共识会议。初始清单由一个核心小组制定,该小组多年来一直参与对有问题的RCT进行评估。我们在一个由包括卫生专业人员、审稿人、期刊编辑、政策制定者、研究人员和证据综合专家在内的多个利益相关者组成的共识小组中进行了试点。要求每位成员使用该清单对三篇文章进行评分,然后在共识会议上讨论结果。
随机临床试验可信度(TRACT)清单包括19个条目,分为七个领域,适用于每一项RCT:1)治理,2)作者团队,3)干预措施使用的合理性,4)时间框架,5)失访率,6)基线特征,以及7)结果。每个条目可以回答为无问题、有一些问题/无信息或有重大问题。如果一项研究经评估发现大多数条目被评为重大问题级别,那么编辑、审稿人或证据综合者应考虑进行更全面的调查,包括对原始个体参与者数据的评估。
TRACT清单是专门为检测RCT中的可信度问题而制定的首个清单。它可能有助于编辑、出版商和研究人员以透明且可重复的方式在提交或已发表的RCT中筛选此类问题。